Mitochondria have long been known as the ‘powerhouse of the cell’, but it has taken several decades for their essential role in human diseases and as a therapeutic target to be fully acknowledged. This article discusses the recent surge in interest in translating basic mitochondrial research into clinical therapies.
No takes yet. Share an insight, caveat, or question.
Mark Greener (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: